+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Health-based risk adjustment Improving the pharmacy-based cost group model to reduce gaming possibilities



Health-based risk adjustment Improving the pharmacy-based cost group model to reduce gaming possibilities



European Journal of Health Economics 4(2): 107-114



The pharmacy-based cost group (PCG) model uses medication prescribed to individuals in a base-year as marker for chronic conditions which are employed to adjust capitation payments to their health plans in the subsequent year. Although the PCG model enhances predictive performance, possibilities for gaming may arise as it is based on prior utilization. This study investigates several strategies to mitigate this problem. The best strategies appear to be: use a (high) number of prescribed daily doses to assign persons to PCGs, do not allow for comorbidity, and remove PCGs with low future costs. This PCG model accounts for almost twice as much variance as do demographic models. In 2002 the Dutch government implemented this model in the sickness fund sector (two-thirds of the population).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049195522

Download citation: RISBibTeXText

PMID: 15609177

DOI: 10.1007/s10198-002-0159-9


Related references

Health-based risk adjustment: improving the pharmacy-based cost group model by adding diagnostic cost groups. Inquiry 44(4): 469-480, 2008

Health-Based Risk Adjustment: Improving the Pharmacy-Based Cost Group Model by Adding Diagnostic Cost Groups. Inquiry - Journal of Health Care Organization, Provision & Financing 44(4): 469-480, 2007

An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan. Bmc Medicine 8: 7, 2010

The Medicaid Rx model: pharmacy-based risk adjustment for public programs. Medical Care 39(11): 1188-1202, 2001

Risk-adjusted capitation based on the Diagnostic Cost Group Model: an empirical evaluation with health survey information. Health Services Research 33(6): 1727-1744, 1999

The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy 68(1): 113-121, 2004

Pharmacy- and Diagnosis-Based Risk Adjustment for Children With Medicaid. Medical Care 43(11): 1155-1159, 2005

Pharmacy-and diagnosis-based risk adjustment for children with Medicaid. Medical Care 43(11): 1155-1159, 2005

The differences between claim-based health risk adjustment models and cost prediction models. Disease Management 7(2): 153-158, 2004

The Medicaid RxModel: Pharmacy-Based Risk Adjustment for Public Programs. Medical Care 39(11): 1188-1202, 2001

Setting health care capitations through diagnosis-based risk adjustment: a suitable model for the English NHS?. Health Policy 101(2): 133-139, 2011

Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Medical Care 41(6): 753-760, 2003

Predicting Costs of Care Using a Pharmacy-Based Measure Risk Adjustment in a Veteran Population. Medical Care 41(6): 753-760, 2003

Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. Journal of Public Health Medicine 25(2): 144-153, 2003

Principal inpatient diagnostic cost group model for Medicare risk adjustment. Health Care Financing Review 21(3): 93, 2000